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C M E E pilepsy, sometimes also referred to as a seizure disorder, is one of the three most common neurologic disorders (with headaches and school problems) seen in a pediatric practice setting. Despite rapid advances in new medications and technology, such as video EEG monitoring and epilepsy surgery, there are a limited number of pediatric neurologists and epileptologists. Therefore, it is essential that pediatricians be well-versed in the recognition, management and outcome of pediatric seizures. This article provides an overview of seizure assessment and management in the pediatric setting, including seizure classifi cation, differentiation between seizures and nonepileptic events, initial seizure work-up, commonly used anti-epileptic medications, seizures associated with neurocutaneous disorders, infantile spasms, febrile seizures, sudden death in epilepsy, and common comorbidities in pediatric seizure.
TERMINOLOGY
A seizure is a paroxysmal clinical event of the central nervous system, characterized by an abnormal electrical discharge and associated with a change in the usual functioning. A seizure occurs when there is a sudden imbalance between the excitatory and inhibitory inputs to a network of neurons in the cerebral cortex, so that there is overall excessive excitability.
Epilepsy is a chronic disorder characterized by recurrent unprovoked seizures. The diagnosis of epilepsy is made when a child has two or more unprovoked seizures -that is, seizures not associated with triggers such as sleep deprivation, infection, trauma, intake of alcohol or the use of illicit drugs. Population-based studies have demonstrated a cumulative lifetime risk of having at least one seizure to be about 10%. [REF-ERENCE] There is a higher incidence of seizures in both the elderly and the very young, with many epileptic syndromes presenting in childhood.
Epilepsy affects 0.5% to 1% of children up to age 16. 1 In children with developmental disabilities, the incidence of epilepsy increases by 30% to 50%. 2 Mortality is increased in people with epilepsy, but increased risk in childhood occurs primarily in children with associated neurologic abnormalities or intractable epilepsy. Epilepsy has a variety of causes, both genetic and acquired. The majority of new-onset epilepsy in children is idiopathic.
SEIZURE CLASSIFICATION
The classifi cation of the seizure is critical for diagnosis and management. Seizures are classifi ed on the basis of clinical event and electroencephalographic abnormalities (Sidebar 1, see page xxx). Seizures can be grouped into two broad categories, partial (focal) or generalized. Other events also may at fi rst appear to be seizures.
Partial (Focal) Seizures
Partial (focal) seizures arise from a discrete area of the cortex of the brain.
Partial seizures can be either complex (impaired consciousness) or simple (no impairment of consciousness.) Complex partial seizures rarely begin with just tonic-clonic movements but typically start with some degree of impairment of consciousness and are then followed by automatic uncontrolled behaviors called automatisms. Automatisms may consist of unusual or typical body movements without purpose, such as lip smacking, gesturing, or repeating words or phrases.
Simple partial seizures can present as simple hand twitching or a focal sensation of a limb. They manifest clinically according to the part of the brain that is affected -motor, sensory, visual, auditory, olfactory, gustatory, or affective. Simple or complex partial seizures can rapidly generalize (spread) to involve the entire brain, so that it may be unclear clinically that the seizure actually began as a partial (focal) seizure onset, thus making accurate diagnosis and treatment complicated.
Generalized Seizures
Generalized seizures arise from the whole brain -that is, there is no one specifi c "seizure focus" that shows where the seizure begins on electroencephalogram (EEG). Generalized seizures can be characterized by either myoclonic (rapid jerk of body or limbs), atonic (loss of tone, drop attack), tonic (rigidity or stiffness,) tonic-clonic (jerking with stiffness), or absence (staring spells) events. These seizure types also
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Other Events Masquerading as Seizures
It is sometimes diffi cult, especially in small children and infants, to determine whether a paroxysmal event is a seizure or a nonepileptic event. Examples of nonepileptic events include syncopal episodes, refl ux, cardiac events, breathholding, hyperrefl exia, tics, self-stimulatory behaviors, psychogenic events, and dystonia. Particularly if the child is an infant or toddler, clues to the diagnosis may come from an eyewitness's recounting of the event. For example, in breath-holding spells, the child cries, holds his or her breath, becomes cyanotic, and loses consciousness. There may be subsequent postural changes or convulsive or jerking movements. In infantile syncope, there is always a triggering factor, such as a bump on the head or a fright, after which the child becomes pale and loses consciousness secondary to decreased cardiac output (vasovagal response).
Other events that may seem to be seizure activity include tics, Tourette's syndrome, gastrointestinal refl ux, dystonia, and self-stimulatory behaviors (autistic stereotypies). These are summarized in Table 1 (see page xxx).
THE FIRST ENCOUNTER
When a child presents to the offi ce or emergency department for the fi rst time after an unexplained paroxysmal event, the fi rst goal is to stabilize the patient. After the child has been stabilized, the physician must determine if a seizure has occurred, and if so, if it is the child's fi rst episode. Typically, the determination of whether or not a seizure has occurred is based upon the history.
The history should include a detailed description of the event. This is often diffi cult to ascertain because the witness may not be present in the exam room, since the event may have occurred at school, at a friend's home or with a babysitter. It is not uncommon to fi nd that witness's memories of the event focus on the child's respiratory status and color or the lack thereof, as well as the child's lack of responsiveness. They often do not remember the sequence of events. It is important, therefore, to question them more than once, particularly regarding the onset of the event. Questions should include those listed in Sidebar 2 (see page xxx). Precipitating events must be taken into consideration and include sleep deprivation, use of over-the-counter cough and cold medications, use of any other prescribed or illicit medications, and increased stress, all of which may lower the seizure threshold.
The parents should be questioned about whether similar events have occurred in the past and whether the child has ever exhibited staring spells or episodes of confusion, jerking or twitching, or drop attacks. Question carefully, also, about sleep -does the child wake frequently, is he or she a sleepwalker, and is he or she not getting enough sleep? Seizures may occur during sleep and be unnoticed by the family and, again, lack of sleep can lower the seizure threshold. Family history is also important, so the clinician must ask about seizures and epilepsy as well as genetic diseases and whether any family members have ever had similar events.
EVALUATION
The next goal is to determine the cause of the seizure. A full physical examination should be completed, with special attention paid to the skin (checking for neurocutaneous fi ndings,) cranial nerves, refl exes, and cerebellar signs. The American Academy of Neurology Practice Parameter for evaluation of a fi rst nonfebrile seizure in children states that, in the emergency department, the following tests should be performed. 3 Laboratory tests should be based on individual historic or clinical fi ndings and are not necessary in all cases. Tests may include serum sodium, glucose, magnesium, calcium, a complete blood count, and urine toxicology
Computed tomography (CT) should be done in a child of any age who presents with a focal neurological defi cit or who has not returned to baseline within several hours after the seizure Lumbar puncture need not be performed in a child with a fi rst nonfebrile seizure and should be used only if there is concern regarding possible meningitis or encephalitis Electrocardiogram (ECG) should be If the child presents to the offi ce and initial evaluation was previously done in the emergency department, the following tests are recommended:
Electroencephalogram (EEG)
Magnetic resonance imaging (MRI) of the brain should be performed on any child with a signifi cant motor or cognitive impairment of unknown etiology, abnormalities on neurological examination, a seizure of partial (focal) onset, age younger than 1, or EEG results that do not represent a benign partial epilepsy of childhood or primary generalized epilepsy (these include benign Rolandic epilepsy and childhood absence epilepsy).
If the child is known to have epilepsy, CT should be performed if the seizure is different from the usual seizures or there are new focal fi ndings on the examination. In addition, serum levels of any anti-epileptic medications should be obtained (Table 2 , see page xxx), and parents and child should be questioned to uncover any missed medication dosages.
Neurologists will use the results of the EEG to help determine if medications are required. In most instances, this can be a routine EEG (awake and drowsy recording). Starting at about age 10 or in anyone where the seizures arise out of sleep, it is prudent to order a sleepdeprived EEG, so that the child falls asleep during the test. Sleep is a very disinhibited state, thus EEG abnormalities are seen more frequently. However, there has been some recent controversy regarding whether or not sleep-deprived EEGs actually increase the yield of epileptiform abnormalities.
The MRI of the brain is the preferred imaging exam for a patient with seizure and is used to look for structural abnormalities, tumors, and vascular abnormalities. Young children or those with behavioral issues may need to be sedated for the MRI. Table 3 (see page xxx) provides a list of all radiologic testing options in new-onset seizures.
SPECIAL CONSIDERATIONS Febrile Seizures
A febrile seizure is defi ned as a "seizure in association with a febrile illness in the absence of CNS infection or acute electrolyte imbalance in a child older than 6 months of age without prior afebrile seizures."
4 Important things to remember are that a fever may not be present at time of seizure, febrile seizures can occur in any child, and febrile seizures are most common between ages 6 months and 6 years. The peak incidence of febrile seizures is age 18 months, and onset after age 7 is very uncommon.
A simple febrile seizure is an isolated brief generalized seizure, while a complex febrile seizure occurs when the seizure is prolonged (greater than 10 or 15 minutes) or there are multiple seizures within same febrile illness. Risk factors for febrile seizures include a fi rst-or second-degree relative with a history of febrile seizures, a neonatal nursery stay of more than 30 days, a developmental delay, and attendance at day care. 5 When a child presents with a febrile seizure, acute management mandates that serious conditions, including meningitis, encephalitis, electrolyte imbalances, and other acute neurologic illnesses, are sought fi rst. The American Academy of Pediatric guidelines suggest a lumbar puncture be strongly considered in children younger than 12 without an obvious source of the fever, children with a fi rst complex febrile seizure, children with persistent lethargy, or children recently receiving antibiotics. 6 An MRI or CT scan is not necessary for simple febrile seizures, and an EEG is of limited value with a simple febrile seizure. An EEG can be considered if the seizure was complex, there is a family history of epilepsy, or there are pre-existing developmental abnormalities.
In terms of prognosis, about 33% of all children with fi rst febrile seizure will experience a second, and 10% will have 
Classifi cation of Seizures

Partial (focal, local) Seizures
Unclassifi ed Epileptic Seizures
Seizures that cannot be classifi ed because of inadequate or incomplete data three or more.
[REFERENCE] Because the peak age of occurrence is 18 months, children who have febrile seizures at a younger age are more likely to have recurrences. There is an increased risk of febrile seizures with a positive family history of febrile seizures. 7 Parents and caregivers should be instructed in fever prophylaxis, including the use of acetaminophen every 4 hours and ibuprofen every 6 hours. However, there is limited evidence that these measures prevent the febrile seizure.
Neurocutaneous Syndromes
Neurocutaneous syndromes are a group of disorders in which skin lesions are associated with central nervous system abnormalities. Epilepsy is a feature of many of these disorders, most commonly tuberous sclerosis and SturgeWeber syndrome.
Tuberous sclerosis (Figure 1 , see page xxx) is the most common of the neurocutaneous syndromes, occurring in approximately 5 in 100,000 births. It consists of a triad of seizures, learning disorder, and facial angiomas. Two gene loci have been documented; TSC1 is located at 9q34, and codes for the protein hamartin while TSC2, located at 16p13, 3 codes for the protein tuberin. Sporadic TSC2 mutations are associated with the more severe clinical phenotype and present earlier in life with seizures and frequently with infantile spasms, mental retardation, subependymal nodules and cortical tubers, and more severe renal involvement. 7 Epilepsy occurs in approximately 78% to 96% of patients with tuberous sclerosis. 8, 9 Epilepsy occurs in approximately 80% of children with Sturge-Weber syndrome, a sporadically occurring syndrome in which facial capillary angiomas are associated with leptomeningeal angiomas. A port-wine birthmark usually involves the trigeminal nerve and is associated with brain calcifi cations on the ipsilateral side (Figure 2 , see page xxx). Approximately 85% of seizures begin before the second year of life. 5, 8 The seizures are focal, usually ipsilateral to the birthmark, often diffi cult to treat, and with a high incidence of status epilepticus. There is also a high incidence of mental retardation and associated progressive cortical atrophy. Treatment for the seizures usually begins with standard antiepileptics, but early resective surgery is advocated by some to preserve cognitive function. 7 Neurofi bromotosis type 1 ( Figure  3 , see page xxx) is a syndrome associated with multiple café-au-lait spots, neurofi bromas, axillary freckling, Lisch nodules, and abnormalities on the brain MRI. NF-1 is an autosomal dominant disorder with a locus mapped to 17q11. 2 Children with NF-1 frequently are found to have learning disabilities, gliomas, bony dysplasias, attentional issues, and abnormalities on brain MRI, but the incidence of seizures is relatively rare. Approximately 3% to 12% of children with NF have seizures, and an additional 1.5% have infantile spasms. 
Infantile Spasms
Pediatricians frequently are the fi rst to evaluate children with spasms. Parents usually present with complaints of unusual startles or jerking movements on awakening and falling asleep. Infantile spasms are perhaps one of the most devastating of the epilepsy syndromes and may be missed at fi rst. Onset tends to be between ages 4 and 7 months, and the spasms are characterized by a sudden contraction of fl exor or extensor muscle groups of the head, trunk or extremities. Estimated prevalence is 1 in 2,000 to 6,000 live births, with most occurring in children with tuberous sclerosis, hypoxic-ischemic injury, congenital infectious diseases, inborn errors of metabolism, malformations of cortical development, genetic syndromes and chromosomal abnormalities. In a small percentage, the spasms are idiopathic. 15 Clinically, the seizures may present as brief spasms with head drops and extensions of the upper extremities. Often, they are followed by a cry, and they may occur in clusters, many times daily. Presentation may be subtle and can also be confused with benign seizure disorders. Therefore, it is imperative that the pediatrician is aware of the child's developmental progress; it is more common for children with infantile spasms to demonstrate developmental delays either before or after the onset of spasms. 16 The EEG diagnostic for infantile spasms and may show either a hypsarrythmia pattern (generalized disorganization) or a burstsuppression pattern.
The gold standard for treatment of SIDEBAR 2. infantile spasms is adrenocorticotropic hormone (ACTH) given intramuscularly. Other medications that have shown effi cacy include topiramate (Topamax) and vigabatrin (Sabril), which is currently unavailable in the United States. ACTH has the highest responder rate among pharmacologic agents, except perhaps for the use of vigabatrin in those children with tuberous sclerosis and infantile spasms. 17 Mechanisms of action in these medications differ; vigabatrin elevates GABA levels, while it is believed that ACTH suppresses excess production of corticotrophin-releasing hormone, reducing epileptogenicity and neuronal damage.
Questions to Ask When Taking A Seizure History
Initiation of ACTH treatment usually is done as an inpatient. Monitoring of blood chemistry, complete blood count, urine for glucose, stool for blood, and blood pressure for hypertension is done before and after treatment. Caregivers are taught intramuscular administration of the medication, and referral to a visiting nurse service is made. The child is treated from 2 to 4 weeks with ACTH, with continued monitoring at home and weekly visits to the neurologist. After discharge, blood is drawn at least weekly.
Depending on outcome and protocol, the medication may later be changed to oral prednisone and tapered slowly. Children with infantile spasms have a very high risk of developing other types of epilepsy and frequently become patients with intractable seizures.
Sudden Unexplained Death In Epilepsy
It is common for anyone witnessing a seizure to assume that the person experiencing the seizure is dying, and one of the fi rst questions asked by the parents of any child with epilepsy is, "Will my child die of a seizure?" There is a higher mortality associated with the diagnosis of epilepsy, but it does vary according to certain risk factors. A recent review of population-based studies from both developing countries and industrial nations found mortality is higher in males than in females, single unprovoked seizures reveal little increase in mortality while poorly controlled seizures have an increased risk of sudden death, and there is little or borderline increase in mortality for people with idiopathic epilepsy. Additionally, mortality in selected popu- 
Medication
MANAGEMENT
After it has been determined that an event was a seizure, the next step is to determine whether the event was a response to an acute disorder (eg, fever, hypoglycemia, hyponatremia, hyperglycemia, meningitis, head trauma) or a response to an exogenous factor (eg, alcohol, drugs, toxins, medications that lower the seizure threshold, lack of sleep). If the child has no previous history of seizures and the seizure was precipitated by one of the above events, efforts are directed at correcting the precipitating event, and further work-up is not necessary. The child does not meet the criteria for epilepsy and does not need to begin preventative medications. Acute provoked seizures are by defi nition a reaction of the brain to metabolic stress, injury, or infl ammation. Again, a diagnosis of epilepsy is made when the child has two or more unprovoked seizures or one unprovoked seizure with an abnormal EEG. At that time, consideration is given as to whether anti-epileptic medication should be initiated.
Medications Used for the Chronic Treatment of Epilepsy
A decision to treat is based on the number of seizures, the time interval between seizures, and abnormalities on the EEG. When there are two or more unprovoked seizures, or one unprovoked seizure with an abnormal EEG, the decision is usually made to treat with medication.
The general rule for treating epilepsy involves initiation with monotherapy. Overall, about 60% of seizures are controlled with the fi rst anti-epileptic drug.
[REFERENCE] The goal of epilepsy treatment is to control the seizures with the medication or treatment having the fewest side effects. The decision making process involving which medication to use includes several factors, including the seizure type, existence of an underlying syndrome, age of the child, formulations available, and common side effects.
In the past 10 years, a number of different medications have been approved by the Food and Drug Administration for treatment of recurrent seizures in children ( Table 2 ). These medications have been used for some time by epileptologists. Specifi cally, oxcarbazepine (Trileptil) has been approved as monotherapy and adjunctive therapy for partial and secondarily generalized seizures in children 4 and older. Lamotrigine (Lamictil) is approved for use as adjunctive therapy for partial seizures in children 2 and older. Levetiracetam (Keppra) is approved for adjunctive therapy for partial seizures in children four years and older. Topiramate (Topamax) is approved as adjunctive therapy for partial and secondarily generalized seizures and primary generalized tonic-clonic seizures in children older than 2 and for initial monotherapy in children older than 10.
Dosing guidelines and information regarding side effects are included in Table 2 . It is important to remember that nearly all of the anti-epileptic drugs carry a risk of bone metabolism abnormalities. For the most part, children on anti-epileptic drugs should also be treated with a multivitamin and possibly calcium carbonate with vitamin D. Folic acid should be supplemented in girls of child-bearing age. 8 The side effects associated with the use of anti-epileptic drugs include rash, hirsutism, and weight gain or loss. Severe side effects such as hepatic toxicity, Stevens-Johnson syndrome, and bone marrow toxicity may occur. If these occur, the medication should be stopped and the symptoms treated. These severe reactions cannot be anticipated and require early recognition of symptoms. Fairly frequently, children on anti-epileptic medications may experience behavioral changes and changes in cognition, which are often dose-related. 8 In all seizures, decisions regarding administration of medication are infl uenced by the child's age, sex, underlying EEG abnormalities, and epilepsy syndromes. Two-thirds of children with no underlying structural abnormalities and normal development ultimately achieve cessation of seizures. Usually, children are weaned off of medication after being seizure-free for 2 to 5 years while receiving medication and having a normal EEG. Of these, 70% remain seizurefree. 1 Predictors of poor outcome include seizure recurrence in the fi rst months after therapy initiation and developmental delay at onset. 9 Families and caregivers of children with seizures should be provided with emergency management guidelines to minimize trips to the emergency department. Rectal diazepam can be administered to stop a seizure and is the only medication currently FDA-approved for acute at-home use for treatment of seizures. Rectal diazepam is available in several different dosages, with all dispensed in either a 10 mg twinpak (with a 4.4-cm tip) or a 20 mg twinpak (with a 6-cm tip.) Dosing should be from 0.2 to 0.5 mg/kg as needed for a seizure lasting more than 5 minutes. The 10 mg can deliver doses of either 5 mg, 7.5 mg, or 10 mg (preset by pharmacist,) while 20 mg can deliver doses of 10 mg, 12.5 mg, 15 mg, 17.5 mg, or 20 mg. The risk of respiratory depression is almost nonexistent with administration of this medication. Families should be provided with information on administration and a plan for when to administer the medication.
ASSOCIATED PROBLEMS IN CHILDREN WITH EPILEPSY
It is well established that children with epilepsy have more associated learning, emotional, and behavioral problems than the general population. It is often management of these associated problems that is more diffi cult for both the family and the clinician than is the management of the seizures themselves.
Up to 30% of children with epilepsy have cognitive problems severe enough to warrant placement in special schools. Factors contributing to poor academic performance in these children include poorly controlled seizures, underlying brain lesions, side effects of medications and social issues. [19] [20] [21] [22] Children with frequent seizures tend to have more behavioral problems, and the families of children experience signifi cant amounts of stress. In fact, children with epilepsy have worse healthrelated quality of life outcomes than do children with other chronic diseases. This may be result of the stigma associated with epilepsy, including restrictions from certain physical activities, social exclusion, and high rates of maternal anxiety.
22,23
SUMMARY
It is not unusual for the primary care provider to have a child present with unusual paroxysmal events or dermatological lesions that bear further investigation. Although most children with epilepsy are treated and managed by pediatric neurologists, it is imperative that the primary care provider have a clear understanding of associated comorbidities, as well as information on the available anti-epileptic drugs, their side effects, and the need for further monitoring.
Those children with epilepsy whose seizures become intractable, failing to be controlled with three or more medications used appropriately at adequate doses, should be referred to a comprehensive epilepsy center for consideration for other treatments. These may include the ketogenic diet, vagal nerve stimulation, or epilepsy surgery. 
